SPRING, Texas, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Io Therapeutics, Inc., a privately held pharmaceutical company headquartered in Spring, Texas; announced today presentation at the San Antonio Breast Cancer Symposium, in San Antonio, TX; of data ...
Read MoreADELAIDE, Australia, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Avance Clinical, the award-winning global CRO for biotechs, has announced the launch of its new Diversity in STEM Scholarships , a global initiative designed to support women and ...
Read MoreNew Website: https://gcls.ai GENEVA, Dec. 08, 2025 (GLOBE NEWSWIRE) -- The Geneva College of Longevity Science (GCLS) , in partnership with DrVibe.ai , today announced the launch of the GCLS AI Academy for Longevity Sciences —the ...
Read MoreEXECUTIVE SUMMARY VALLAURIX Research, Development & Innovation Centre to expand its existing facilities and capabilities core focus on accelerating development of liquid long-acting drug delivery platforms existing RD&I teams will advance ...
Read MorePR Newswire HONG KONG, Dec. 8, 2025 - ASC30 once-daily tablets showed statistically significant and clinically meaningful dose-dependent placebo-adjusted mean body weight reductions with no observed plateau for weight loss. - ASC30 ...
Read MorePR Newswire YONGIN, South Korea, Dec. 8, 2025 - First anthrax vaccine developed using recombinant DNA technology- Annual production capacity of up to 10 million doses at GC Biopharma's facility YONGIN, South Korea, Dec. 8, 2025 ...
Read MorePR Newswire BRUSSELS, Dec. 8, 2025 BRUSSELS, Dec. 8, 2025 /PRNewswire/ -- UCB, a global biopharmaceutical company, today presented positive efficacy and safety results from the GEMZ phase 3 study investigating adjunctive fenfluramine in ...
Read MorePR Newswire NEW DELHI, Dec. 8, 2025 NEW DELHI, Dec. 8, 2025 /PRNewswire/ -- In a significant medical achievement, doctors at HCMCT Manipal Hospitals in Delhi, India, successfully performed a life-saving heart transplant on a 54-year-old ...
Read MorePR Newswire SHANGHAI and NANJING, China and PLEASANTON, Calif., Dec. 7, 2025 SHANGHAI and NANJING, China and PLEASANTON, Calif., Dec. 7, 2025 /PRNewswire/ -- IASO Biotechnology ("IASO Bio"), a commercial-stage biopharmaceutical company ...
Read MorePR Newswire SAN FRANCISCO and SUZHOU, China, Dec. 7, 2025 SAN FRANCISCO and SUZHOU, China, Dec. 7, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, ...
Read MorePR Newswire TOKYO, Dec. 8, 2025 TOKYO, Dec. 8, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today an investment of approximately JPY 70 million (USD 460,0001) for the development of a prototype detection ...
Read MorePR Newswire SHANGHAI, Dec. 7, 2025 SHANGHAI, Dec. 7, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced that clinical data from its ...
Read MorePR Newswire SINGAPORE, Dec. 7, 2025 SINGAPORE, Dec. 7, 2025 /PRNewswire/ -- AI/ML health-tech startup Respiree has received approval from the Health Sciences Authority (HSA) for its 1Bio™AI-Acute toolbox as a Class B software-as-a-medical ...
Read MorePR Newswire INDIANAPOLIS, Dec. 7, 2025 In addition to meeting the primary endpoint of non-inferiority for overall response rate (ORR) in the BRUIN CLL-314 study, pirtobrutinib achieved a numerically higher ORR of 87.0% compared to 78.5% for ...
Read More
MEDINDIA
English
हिन्दी
Español
français
中文